Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for Fatigue in Metastatic Breast or Prostate Cancer
NCT00917748Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fatigue comparing Modafinil + Docetaxel with Placebo + Docetaxel (2 arms). Primary endpoint: Fatigue scores (MD Anderson Symptom Inventory) at 12 weeks. Started Jun 2009; status: completed.
02
Drugs
modafinil
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT00917748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00917748.